Related Experiment Video
Updated: Feb 16, 2026

06:33
Production of Human CRISPR-Engineered CAR-T Cells
Published on: March 15, 2021
14.7K
CRISPRed Macrophages for Cell-Based Cancer Immunotherapy.
Moumita Ray1, Yi-Wei Lee1, Joseph Hardie1
1Department of Chemistry, University of Massachusetts , 710 North Pleasant Street, Amherst, Massachusetts 01003, United States.
Bioconjugate Chemistry
|January 4, 2018
Summary
This study developed arginine nanoparticles (ArgNPs) to deliver CRISPR-Cas9 gene editing tools, enhancing macrophage cancer cell targeting. This approach significantly boosts the immune system's ability to eliminate tumors.
Area of Science:
- Nanotechnology
- Immunotherapy
- Gene Editing
Background:
- Cancer immunotherapy faces challenges in effective tumor cell elimination.
- Macrophages play a crucial role in the immune response but can be inhibited from attacking cancer cells by specific signals.
Purpose of the Study:
- To develop a novel nanotechnology-based strategy for cancer immunotherapy.
- To engineer macrophages to enhance their cancer cell phagocytosis (eating) capabilities.
Main Methods:
- Utilized arginine nanoparticles (ArgNPs) for targeted delivery of CRISPR-Cas9 gene editing components.
- Employed single guide RNA (sgRNA) and Cas9 protein for gene editing within macrophages.
- Generated SIRP-α knockout macrophages by disabling the 'don't eat me signal'.
Main Results:
- Successfully delivered CRISPR-Cas9 machinery into cells using ArgNPs.
- Achieved a 4-fold increase in macrophage phagocytic activity against cancer cells.
- Demonstrated enhanced elimination of cancer cells due to modified macrophages.
Conclusions:
- The integrated nanotechnology and gene editing strategy shows promise for cancer immunotherapy.
- Engineered 'weaponized' macrophages offer a potential new approach for cancer treatment.
- Disabling the SIRP-α 'don't eat me signal' effectively enhances macrophage anti-cancer functions.
Related Concept Videos
CRISPR
58.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.0K
CRISPR and crRNAs
19.2K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.2K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Cancer Cell Migration through Invadopodia
3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K

